Knowledge of genotypic resistance mutations among providers of care to patients with human immunodeficiency virus.
A questionnaire assessed clinician knowledge of genotypic resistance mutations in human immunodeficiency virus. Only 24% of respondents were able to identify at least 1 mutation for each of > or =4 drug groups listed, and 36% were unable to match any mutations with any of the drug groups. Knowledge was most deficient among providers caring for < or =50 patients (P=.001) but also was poor among the 38 physicians caring for > or =100 patients (mean patient load, 211 patients).
Salama
Carlos
C
Division of Infectious Diseases and Immunology Clinic, Dept. of Medicine, Elmhurst Hospital Center, Elmhurst, New York 11373 , USA. csalama@yahoo.com
Policar
Maurice
M
Cervera
Christina
C
D003625:Data Collection; D024882:Drug Resistance, Viral / Q000235:genetics*; D005104:Expert Testimony; D005838:Genotype; D006678:HIV / Q000187:drug effects / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D006282:Health Personnel / Q000193:education* / Q000523:psychology; D006801:Humans; D008297:Male; D009154:Mutation; D011795:Surveys and Questionnaires